Kosuke Fujino

Kumamoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Oncological Outcomes of Segmentectomy for Centrally Located Small-Sized Non-small-cell Lung Cancer: A Multicenter Study (CReGYT-02 Study).

Oncological Outcomes of Segmentectomy for Centrally Located Small-Sized Non-small-cell Lung Cancer: A Multicenter Study (CReGYT-02 Study).

Journal: Annals of surgical oncology

Published: March 25, 2026

β-III tubulin identifies anti-fibrotic state of pericytes in pulmonary fibrosis.

β-III tubulin identifies anti-fibrotic state of pericytes in pulmonary fibrosis.

Journal: Research square

Published: December 31, 2025

A lung squamous cell carcinoma demonstrating spontaneous partial regression of the primary tumor with lymph node metastasis: a case report with analysis of the tumor immune microenvironment.

A lung squamous cell carcinoma demonstrating spontaneous partial regression of the primary tumor with lymph node metastasis: a case report with analysis of the tumor immune microenvironment.

Journal: Translational lung cancer research

Published: December 20, 2025

Survival outcomes of patients with uncommon EGFR mutations in surgically resected lung adenocarcinoma: A multi-institutional real-world database study (CReGYT-01 EGFR study).

Survival outcomes of patients with uncommon EGFR mutations in surgically resected lung adenocarcinoma: A multi-institutional real-world database study (CReGYT-01 EGFR study).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: October 14, 2025

Completion lobectomy following segmentectomy for malignant lung tumors: a multi-institutional study of surgical feasibility, oncologic outcomes, and diagnostic challenges (ESSG-02 study).

Completion lobectomy following segmentectomy for malignant lung tumors: a multi-institutional study of surgical feasibility, oncologic outcomes, and diagnostic challenges (ESSG-02 study).

Journal: Translational lung cancer research

Published: September 22, 2025

Phase 2 feasibility study of adjuvant chemotherapy with cisplatin (CDDP) and TS-1, followed by alternate-day TS-1 maintenance therapy, in patients with completely resected pathological stage II-IIIA non-small cell lung cancer.

Phase 2 feasibility study of adjuvant chemotherapy with cisplatin (CDDP) and TS-1, followed by alternate-day TS-1 maintenance therapy, in patients with completely resected pathological stage II-IIIA non-small cell lung cancer.

Journal: Journal of thoracic disease

Published: July 25, 2025

β-III tubulin identifies anti-fibrotic state of pericytes in pulmonary fibrosis.

β-III tubulin identifies anti-fibrotic state of pericytes in pulmonary fibrosis.

Journal: bioRxiv : the preprint server for biology

Published: June 26, 2025

Association of lung silica deposition with epidermal growth factor receptor-mutant lung cancer.

Association of lung silica deposition with epidermal growth factor receptor-mutant lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 02, 2025

Adjuvant therapy in pStage IA1-IIA lung adenocarcinoma (pN0): A multicenter study focusing on EGFR mutations and recurrence patterns (CReGYT-01 EGFR study).

Adjuvant therapy in pStage IA1-IIA lung adenocarcinoma (pN0): A multicenter study focusing on EGFR mutations and recurrence patterns (CReGYT-01 EGFR study).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 30, 2025

Similar Trend in Benefit of Adjuvant Platinum in Lung Cancer Patients Irrespective of Epidermal Growth Factor Receptor Mutation Status.

Similar Trend in Benefit of Adjuvant Platinum in Lung Cancer Patients Irrespective of Epidermal Growth Factor Receptor Mutation Status.

Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Published: April 29, 2025

The expression of PD-1 ligands in the immune microenvironment was altered in TTF-1-negative lung adenocarcinoma.

The expression of PD-1 ligands in the immune microenvironment was altered in TTF-1-negative lung adenocarcinoma.

Journal: Human cell

Published: March 26, 2025

Bronchopleural fistula: a multi-institutional analysis of the treatment outcomes and prognostic factors in the ESSG-01 study.

Bronchopleural fistula: a multi-institutional analysis of the treatment outcomes and prognostic factors in the ESSG-01 study.

Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Published: February 26, 2025

Showing 1-12 of 55

Last Updated: 09/26/2026